The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Needle Biopsy-Global Market Insights and Sales Trends 2024
Synopsis
A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologistinvolving extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is generally examined under a microscope by a pathologist, and can also be analyzed chemically.
The global Needle Biopsy market size is expected to reach US$ 584.5 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Needle Biopsy in various end use industries. The expanding demands from the Tumor, Infection and Inflammation,, are propelling Needle Biopsy market. Fine-Needle Aspiration Biopsy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Core Needle Biopsy segment is estimated at % CAGR for the next seven-year period.
A needle biopsy is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle Biopsy covered in this report include Boston Scientific, Cook Medical, Carefusion, Hologic, Cardinal Health, Medax, CR Bard, MöLler Medical and Becton, Dickinson And Company, etc.
The global Needle Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific
Cook Medical
Carefusion
Hologic
Cardinal Health
Medax
CR Bard
MöLler Medical
Becton, Dickinson And Company
Kompass
Hakko
Global Needle Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle Biopsy market, Segment by Type:
Fine-Needle Aspiration Biopsy
Core Needle Biopsy
Vacuum-Assisted Biopsy
Image-Guided Biopsy
Global Needle Biopsy market, by Application
Tumor
Infection
Inflammation
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Needle Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologistinvolving extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is generally examined under a microscope by a pathologist, and can also be analyzed chemically.
The global Needle Biopsy market size is expected to reach US$ 584.5 million by 2029, growing at a CAGR of 4.2% from 2023 to 2029. The market is mainly driven by the significant applications of Needle Biopsy in various end use industries. The expanding demands from the Tumor, Infection and Inflammation,, are propelling Needle Biopsy market. Fine-Needle Aspiration Biopsy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Core Needle Biopsy segment is estimated at % CAGR for the next seven-year period.
A needle biopsy is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Needle Biopsy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Needle Biopsy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Needle Biopsy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Needle Biopsy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Needle Biopsy covered in this report include Boston Scientific, Cook Medical, Carefusion, Hologic, Cardinal Health, Medax, CR Bard, MöLler Medical and Becton, Dickinson And Company, etc.
The global Needle Biopsy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boston Scientific
Cook Medical
Carefusion
Hologic
Cardinal Health
Medax
CR Bard
MöLler Medical
Becton, Dickinson And Company
Kompass
Hakko
Global Needle Biopsy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Needle Biopsy market, Segment by Type:
Fine-Needle Aspiration Biopsy
Core Needle Biopsy
Vacuum-Assisted Biopsy
Image-Guided Biopsy
Global Needle Biopsy market, by Application
Tumor
Infection
Inflammation
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Needle Biopsy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Needle Biopsy
1.1 Needle Biopsy Market Overview
1.1.1 Needle Biopsy Product Scope
1.1.2 Needle Biopsy Market Status and Outlook
1.2 Global Needle Biopsy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Needle Biopsy Market Size by Region (2018-2029)
1.4 Global Needle Biopsy Historic Market Size by Region (2018-2023)
1.5 Global Needle Biopsy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Needle Biopsy Market Size (2018-2029)
1.6.1 North America Needle Biopsy Market Size (2018-2029)
1.6.2 Europe Needle Biopsy Market Size (2018-2029)
1.6.3 Asia-Pacific Needle Biopsy Market Size (2018-2029)
1.6.4 Latin America Needle Biopsy Market Size (2018-2029)
1.6.5 Middle East & Africa Needle Biopsy Market Size (2018-2029)
2 Needle Biopsy Market by Type
2.1 Introduction
2.1.1 Fine-Needle Aspiration Biopsy
2.1.2 Core Needle Biopsy
2.1.3 Vacuum-Assisted Biopsy
2.1.4 Image-Guided Biopsy
2.2 Global Needle Biopsy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Needle Biopsy Historic Market Size by Type (2018-2023)
2.2.2 Global Needle Biopsy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Needle Biopsy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Needle Biopsy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Needle Biopsy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Needle Biopsy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Needle Biopsy Revenue Breakdown by Type (2018-2029)
3 Needle Biopsy Market Overview by Application
3.1 Introduction
3.1.1 Tumor
3.1.2 Infection
3.1.3 Inflammation
3.2 Global Needle Biopsy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Needle Biopsy Historic Market Size by Application (2018-2023)
3.2.2 Global Needle Biopsy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Needle Biopsy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Needle Biopsy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Needle Biopsy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Needle Biopsy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Needle Biopsy Revenue Breakdown by Application (2018-2029)
4 Needle Biopsy Competition Analysis by Players
4.1 Global Needle Biopsy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Needle Biopsy as of 2022)
4.3 Date of Key Players Enter into Needle Biopsy Market
4.4 Global Top Players Needle Biopsy Headquarters and Area Served
4.5 Key Players Needle Biopsy Product Solution and Service
4.6 Competitive Status
4.6.1 Needle Biopsy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boston Scientific
5.1.1 Boston Scientific Profile
5.1.2 Boston Scientific Main Business
5.1.3 Boston Scientific Needle Biopsy Products, Services and Solutions
5.1.4 Boston Scientific Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.1.5 Boston Scientific Recent Developments
5.2 Cook Medical
5.2.1 Cook Medical Profile
5.2.2 Cook Medical Main Business
5.2.3 Cook Medical Needle Biopsy Products, Services and Solutions
5.2.4 Cook Medical Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.2.5 Cook Medical Recent Developments
5.3 Carefusion
5.3.1 Carefusion Profile
5.3.2 Carefusion Main Business
5.3.3 Carefusion Needle Biopsy Products, Services and Solutions
5.3.4 Carefusion Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.3.5 Hologic Recent Developments
5.4 Hologic
5.4.1 Hologic Profile
5.4.2 Hologic Main Business
5.4.3 Hologic Needle Biopsy Products, Services and Solutions
5.4.4 Hologic Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.4.5 Hologic Recent Developments
5.5 Cardinal Health
5.5.1 Cardinal Health Profile
5.5.2 Cardinal Health Main Business
5.5.3 Cardinal Health Needle Biopsy Products, Services and Solutions
5.5.4 Cardinal Health Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.5.5 Cardinal Health Recent Developments
5.6 Medax
5.6.1 Medax Profile
5.6.2 Medax Main Business
5.6.3 Medax Needle Biopsy Products, Services and Solutions
5.6.4 Medax Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.6.5 Medax Recent Developments
5.7 CR Bard
5.7.1 CR Bard Profile
5.7.2 CR Bard Main Business
5.7.3 CR Bard Needle Biopsy Products, Services and Solutions
5.7.4 CR Bard Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.7.5 CR Bard Recent Developments
5.8 MöLler Medical
5.8.1 MöLler Medical Profile
5.8.2 MöLler Medical Main Business
5.8.3 MöLler Medical Needle Biopsy Products, Services and Solutions
5.8.4 MöLler Medical Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.8.5 MöLler Medical Recent Developments
5.9 Becton, Dickinson And Company
5.9.1 Becton, Dickinson And Company Profile
5.9.2 Becton, Dickinson And Company Main Business
5.9.3 Becton, Dickinson And Company Needle Biopsy Products, Services and Solutions
5.9.4 Becton, Dickinson And Company Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.9.5 Becton, Dickinson And Company Recent Developments
5.10 Kompass
5.10.1 Kompass Profile
5.10.2 Kompass Main Business
5.10.3 Kompass Needle Biopsy Products, Services and Solutions
5.10.4 Kompass Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.10.5 Kompass Recent Developments
5.11 Hakko
5.11.1 Hakko Profile
5.11.2 Hakko Main Business
5.11.3 Hakko Needle Biopsy Products, Services and Solutions
5.11.4 Hakko Needle Biopsy Revenue (US$ Million) & (2018-2023)
5.11.5 Hakko Recent Developments
6 North America
6.1 North America Needle Biopsy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Needle Biopsy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Needle Biopsy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Needle Biopsy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Needle Biopsy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Needle Biopsy Market Dynamics
11.1 Needle Biopsy Industry Trends
11.2 Needle Biopsy Market Drivers
11.3 Needle Biopsy Market Challenges
11.4 Needle Biopsy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
